Manufacturer-Direct vs Telehealth: Where to Actually Buy a GLP-1

For most of the GLP-1 era there were two options: pay well over $1,000 a month for brand-name medication, or use a telehealth company selling compounded semaglutide for a fraction of that. A third route has since opened, and it changes the maths for a lot of people — the drug makers now sell directly to patients, at prices close to what compounders charge.

The Three Routes, Compared

Every way of getting a GLP-1 falls into one of three buckets, and they differ on price, on what you are actually receiving, and on how much you have to verify yourself.

• Manufacturer-direct. LillyDirect and NovoCare Pharmacy are operated by the drug makers. You get the FDA-approved product with no compounding pharmacy to vet. You must already have a prescription — these are pharmacies, not clinics.
• Compounded telehealth. A platform connects you to a clinician who prescribes a compounded version, prepared by a 503A or 503B pharmacy. Cheapest route, typically $79 to $299 a month, but compounded drugs are not FDA-approved and the FDA does not review them for safety, effectiveness or manufacturing quality.
• Insurance. If a prior authorization is approved, a brand-name GLP-1 can cost as little as $25 a month. This beats every cash price — it is simply harder to obtain, and many employer plans exclude weight-loss indications outright.

The Reseller Markup, in Numbers

These are published cash prices for identical, FDA-approved medication. The only difference between the columns is who is selling it to you.

• Zepbound (tirzepatide): $299–$449/month at LillyDirect · $1,249 at altRx · $1,498 at OrderlyMeds
• Wegovy (semaglutide): $149–$199/month at NovoCare · $1,579 at altRx · $1,599 at Lemonaid · $1,839 at OrderlyMeds
• Ozempic (semaglutide): $149–$199/month at NovoCare · $1,149 at altRx · $1,199 at Lemonaid

A reseller is selling convenience and access to a prescriber. That has some value — but not four figures a month of value. If a platform quotes you over $1,000 for brand-name medication, check the manufacturer-direct price before agreeing to anything.

Where Manufacturer-Direct Gets Awkward

The direct route is not frictionless, and two pieces of fine print cost real money:

• LillyDirect's 45-day refill rule. The $449/month maintenance price for 7.5mg and above only applies if you refill within 45 days of your previous delivery. Outside that window it is $499 or $699 depending on dose — a $250/month penalty for being late.
• NovoCare's introductory pen pricing. The $199 pen rate covers two monthly fills through December 31, 2026, after which Wegovy is $349/month. The pill pricing is not introductory, but it does climb with dose, reaching $299 at the highest strengths.
• Neither employs clinicians. You need a prescription from your own doctor or an independent telehealth provider. Some services, like Amazon One Medical, bundle the prescriber and pharmacy together at similar prices.
• Self-pay does not touch your deductible. Lilly states this explicitly. If you expect to hit your out-of-pocket maximum anyway, running the medication through insurance may be worth more than the lower cash price.

So Is Compounded Still Worth It?

Sometimes — but the gap has narrowed enough that it deserves a real decision rather than a reflex. Compounded semaglutide starts around $79 to $99 a month against $149 direct. Compounded tirzepatide runs roughly $125 to $179 against $299.

So you are weighing roughly $50 to $170 a month against a product the FDA has reviewed, from a supply chain you do not have to investigate. If you do go compounded, choose a provider that names its pharmacy — our transparency rankings order them on exactly that.